{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:56:22Z","timestamp":1778511382127,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T00:00:00Z","timestamp":1507248000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s12032-017-1045-8","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T10:57:52Z","timestamp":1507287472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Timeline metastatic progression: in the wake of the \u00ab\u00a0seed and soil\u00a0\u00bb theory"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3659-291X","authenticated-orcid":false,"given":"Aymeric","family":"Amelot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis-Marie","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Mazeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles-Ambroise","family":"Valery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Leveque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"1045_CR1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"1045_CR2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/1096-9098(199601)61:1<68::AID-JSO2930610102>3.0.CO;2-E","volume":"61","author":"JS Spratt","year":"1996","unstructured":"Spratt JS, Meyer J, Spratt JA. Rates of growth of human neoplasms: part II. J Surg Oncol. 1996;61:68\u201383.","journal-title":"J Surg Oncol"},{"key":"1045_CR3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","volume":"1","author":"S Paget","year":"1889","unstructured":"Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571\u20133.","journal-title":"Lancet"},{"key":"1045_CR4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/1097-0142(195205)5:3<606::AID-CNCR2820050324>3.0.CO;2-U","volume":"5","author":"D Sugarbaker","year":"1952","unstructured":"Sugarbaker D. Organ selectivity of experimentally induced metastases in rats. Cancer. 1952;5:606\u201312.","journal-title":"Cancer"},{"key":"1045_CR5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/1097-0142(196007\/08)13:4<674::AID-CNCR2820130405>3.0.CO;2-Q","volume":"13","author":"DL Kinsey","year":"1960","unstructured":"Kinsey DL. An experimental study of preferential metastasis. Cancer. 1960;13:674\u20136.","journal-title":"Cancer"},{"key":"1045_CR6","first-page":"2281","volume":"40","author":"IR Hart","year":"1980","unstructured":"Hart IR, Fidler IJ. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res. 1980;40:2281\u20137.","journal-title":"Cancer Res"},{"key":"1045_CR7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","volume":"2","author":"AF Chambers","year":"2002","unstructured":"Chambers AF, Groom AC, Mac Donald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2:563\u201372.","journal-title":"Nat Rev Cancer"},{"key":"1045_CR8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"G Gupta","year":"2006","unstructured":"Gupta G, Massague J. Cancer metastasis: building a framework. Cell. 2006;127:679\u201395.","journal-title":"Cell"},{"key":"1045_CR9","volume-title":"Neoplastic diseases","author":"J Ewing","year":"1928","unstructured":"Ewing J. Neoplastic diseases. Philadelphia: WB Saunders; 1928."},{"key":"1045_CR10","first-page":"197","volume":"2","author":"GA Turner","year":"1982","unstructured":"Turner GA. Surface properties of the metastatic cell. Invasion Metastasis. 1982;2:197\u2013216.","journal-title":"Invasion Metastasis"},{"key":"1045_CR11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00048097","volume":"4","author":"CL Reading","year":"1985","unstructured":"Reading CL, Hutchins JF. Carbohydrate structure in tumor immunity. Cancer Metastasis Rev. 1985;4:221\u201360.","journal-title":"Cancer Metastasis Rev"},{"key":"1045_CR12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF00144274","volume":"6","author":"A Raz","year":"1987","unstructured":"Raz A, Lotan R. Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev. 1987;6:433\u201352.","journal-title":"Cancer Metastasis Rev"},{"key":"1045_CR13","first-page":"3517","volume":"45","author":"ES Hujanen","year":"1985","unstructured":"Hujanen ES, Terranova VP. Migration of tumor cells to organ derived chemoattractants. Cancer Res. 1985;45:3517\u201321.","journal-title":"Cancer Res"},{"key":"1045_CR14","first-page":"175","volume":"948","author":"GL Nicolson","year":"1988","unstructured":"Nicolson GL. Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta. 1988;948:175\u2013224.","journal-title":"Biochim Biophys Acta"},{"key":"1045_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00046483","volume":"7","author":"GL Nicolson","year":"1988","unstructured":"Nicolson GL. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev. 1988;7:143\u201388.","journal-title":"Cancer Metastasis Rev"},{"key":"1045_CR16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ijc.2910380221","volume":"38","author":"GL Nicolson","year":"1986","unstructured":"Nicolson GL, Dulski KM. Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells. Int J Cancer. 1986;38:289\u201394.","journal-title":"Int J Cancer"},{"key":"1045_CR17","first-page":"601","volume":"97","author":"L Weiss","year":"1979","unstructured":"Weiss L. Dynamic aspects of cancer cell populations in metastasis. Am J Pathol. 1979;97:601\u20138.","journal-title":"Am J Pathol"},{"key":"1045_CR18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00049529","volume":"5","author":"IJ Fidler","year":"1986","unstructured":"Fidler IJ. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev. 1986;5:29\u201349.","journal-title":"Cancer Metastasis Rev"},{"key":"1045_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00049477","volume":"1","author":"I Hart","year":"1982","unstructured":"Hart I. Seed and soil\u2019 revisited: mechanisms of site-specific metastasis. Cancer Metastasis Rev. 1982;1:5\u201316.","journal-title":"Cancer Metastasis Rev"},{"key":"1045_CR20","first-page":"1","volume":"72","author":"G Klein","year":"1998","unstructured":"Klein G. Foulds\u2019 dangerous idea revisited: the multistep development of tumors 40\u00a0years later. Adv Cancer Res. 1998;72:1\u201323.","journal-title":"Adv Cancer Res"},{"key":"1045_CR21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759\u201367.","journal-title":"Cell"},{"issue":"1","key":"1045_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","volume":"86","author":"M Riihim\u00e4ki","year":"2014","unstructured":"Riihim\u00e4ki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J, et al. Metastatic sites and survival in lung cancer. Lung Cancer. 2014;86(1):78\u201384. doi:\n                        10.1016\/j.lungcan.2014.07.020\n                        \n                     (Epub 2014 Aug 2).","journal-title":"Lung Cancer"},{"key":"1045_CR23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc2627","volume":"9","author":"CA Klein","year":"2009","unstructured":"Klein CA. Parallel progression of primary tumours and metastasis. Nat Rev Cancer. 2009;9:302\u201312.","journal-title":"Nat Rev Cancer"},{"key":"1045_CR24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ncponc0558","volume":"3","author":"I Weinstein","year":"2006","unstructured":"Weinstein I, Joe AK. Mechanisms of disease: oncogene addiction, a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol. 2006;3:448\u201357.","journal-title":"Nat Clin Pract Oncol"},{"issue":"6","key":"1045_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc3265","volume":"12","author":"T Brabletz","year":"2012","unstructured":"Brabletz T. To differentiate or not routes towards metastasis. Nat Rev Cancer. 2012;12(6):425\u201336. doi:\n                        10.1038\/nrc3265\n                        \n                    .","journal-title":"Nat Rev Cancer"},{"key":"1045_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000331643","volume":"6","author":"Z Elsawaf","year":"2011","unstructured":"Elsawaf Z, Sinn H. Triple-negative breast cancer: clinical and histological correlations. Breast Care. 2011;6:273\u20138.","journal-title":"Breast Care"},{"key":"1045_CR27","first-page":"1","volume":"16","author":"T Laurberg","year":"2016","unstructured":"Laurberg T, Alsner J, Tramm T, Jensen V, Lyngholm C, Christiansen P, et al. Impact of age, intrinsic subtype and local treatment on long-term local regional recurrence and breast cancer mortality among low-risk breast cancer patients. Acta Oncol. 2016;16:1\u20139.","journal-title":"Acta Oncol"},{"issue":"1","key":"1045_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10585-016-9830-x","volume":"34","author":"B Szekely","year":"2017","unstructured":"Szekely B, Nagy ZI, Farago Z, Kiss O, Lotz G, Kovacs KA, et al. Comparison of immunophenotypes of primary breast carcinomas and multiple corresponding distant metastasis: an autopsy study of 25 patients. Clin Exp Metastasis. 2017;34(1):103\u201313. doi:\n                        10.1007\/s10585-016-9830-x\n                        \n                     (Epub 2016 Nov 24).","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"1045_CR29","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s12032-012-0408-4","volume":"30","author":"A Niwi\u0144ska","year":"2013","unstructured":"Niwi\u0144ska A, Rudnicka H, Murawska M. Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival. Med Oncol. 2013;30(1):408. doi:\n                        10.1007\/s12032-012-0408-4\n                        \n                    .","journal-title":"Med Oncol"},{"key":"1045_CR30","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1158\/1078-0432.CCR-08-2132","volume":"15","author":"EA Rakha","year":"2009","unstructured":"Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, et al. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res. 2009;15:2302\u201310. doi:\n                        10.1158\/1078-0432.CCR-08-2132\n                        \n                    .","journal-title":"Clin Cancer Res"},{"key":"1045_CR31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0955-0674(97)80061-0","volume":"9","author":"MJ Robinson","year":"1997","unstructured":"Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997;9:180\u20136.","journal-title":"Curr Opin Cell Biol"},{"key":"1045_CR32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nrm1498","volume":"5","author":"C Wellbrock","year":"2004","unstructured":"Wellbrock C, Karasarides M, Marais R. The RAF proteins take centre stage. Nat Rev Mol Cell Biol. 2004;5:875\u201385.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1045_CR33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","volume":"116","author":"PT Wan","year":"2004","unstructured":"Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, et al. Mechanism of activation of the RAF\u2013ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004;116:855\u201367.","journal-title":"Cell"},{"key":"1045_CR34","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1371\/journal.pone.0000236","volume":"2","author":"S Ugurel","year":"2007","unstructured":"Ugurel S, Thirumaran RK, Bloethner S, Gast A, Sucker A, Mueller-Berghaus J, et al. B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis. PLoS ONE. 2007;2:e236.","journal-title":"PLoS ONE"},{"issue":"7","key":"1045_CR35","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/modpathol.2016.66","volume":"29","author":"F Schneider","year":"2016","unstructured":"Schneider F, Derrick V, Davison JM, Strollo D, Incharoen P, Dacic S. Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging. Mod Pathol. 2016;29(7):735\u201342. doi:\n                        10.1038\/modpathol.2016.66\n                        \n                    .","journal-title":"Mod Pathol"},{"key":"1045_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00000658-196402000-00001","volume":"159","author":"JS Spratt","year":"1964","unstructured":"Spratt JS, Spratt TL. Rates of growth of pulmonary metastasis and host survival. Ann Surg. 1964;159:161\u201371.","journal-title":"Ann Surg"},{"issue":"11","key":"1045_CR37","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.21873\/anticanres.11154","volume":"36","author":"P Chanvorachote","year":"2016","unstructured":"Chanvorachote P, Chamni S, Ninsontia C, Phiboonchaiyanan PP. Potential anti-metastasis natural compounds for lung cancer. Anticancer Res. 2016;36(11):5707\u201317.","journal-title":"Anticancer Res"},{"key":"1045_CR38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1158\/1078-0432.CCR-0424-03","volume":"10","author":"A Ulmer","year":"2004","unstructured":"Ulmer A, Schmidt-Kittler O, Fischer J, Ellwanger U, Rassner G, Riethm\u00fcller G, et al. Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells. Clin Cancer Res. 2004;10:531\u20137.","journal-title":"Clin Cancer Res"},{"key":"1045_CR39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","volume":"351","author":"M Cristofanilli","year":"2004","unstructured":"Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781\u201391.","journal-title":"N Engl J Med"},{"key":"1045_CR40","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/cncr.23852","volume":"113","author":"S Dawood","year":"2008","unstructured":"Dawood S, Broglio K, Valero V, Reuben J, Handy B, Islam R, et al. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer. 2008;113:2422\u201330.","journal-title":"Cancer"},{"key":"1045_CR41","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1101\/gr.191098.115","volume":"25","author":"NE Navin","year":"2015","unstructured":"Navin NE. The first five years of single-cell cancer genomics and beyond. Genome Res. 2015;25:1499\u2013507.","journal-title":"Genome Res"},{"key":"1045_CR42","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158:1110\u201322.","journal-title":"Cell"},{"key":"1045_CR43","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/onc.2013.94","volume":"33","author":"LG Daenen","year":"2014","unstructured":"Daenen LG, Houthuijzen JM, Cirkel GA, Roodhart JM, Shaked Y, Voest EE. Treatment-induced host-mediated mechanisms reducing the efficacy of antitumor therapies. Oncogene. 2014;33:1341\u20137.","journal-title":"Oncogene"},{"key":"1045_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-74039-3_1","volume":"608","author":"AM Gonzalez-Angulo","year":"2007","unstructured":"Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol. 2007;608:1\u201322.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"1045_CR45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nm.2072","volume":"16","author":"Y Kienast","year":"2010","unstructured":"Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J, et al. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med. 2010;16(1):116\u201322.","journal-title":"Nat Med"},{"issue":"1","key":"1045_CR46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/jcbfm.2012.153","volume":"33","author":"LL Muldoon","year":"2013","unstructured":"Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, et al. Immunologic privilege in the central nervous system and the blood\u2013brain barrier. J Cereb Blood Flow Metab. 2013;33(1):13\u201321.","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-017-1045-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-017-1045-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-017-1045-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T01:54:16Z","timestamp":1509587656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-017-1045-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["1045"],"URL":"https:\/\/doi.org\/10.1007\/s12032-017-1045-8","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,6]]},"article-number":"185"}}